Literature DB >> 27469459

Monomeric adiponectin modulates nitric oxide release and calcium movements in porcine aortic endothelial cells in normal/high glucose conditions.

Elena Grossini1, Serena Farruggio2, Fatima Qoqaiche2, Giulia Raina2, Lara Camillo2, Lorenzo Sigaudo2, David Mary2, Nicola Surico3, Daniela Surico3.   

Abstract

AIMS: Perivascular adipose tissue can be involved in the process of cardiovascular pathology through the release of adipokines, namely adiponectins. Monomeric adiponectin has been shown to increase coronary blood flow in anesthetized pigs through increased nitric oxide (NO) release and the involvement of adiponectin receptor 1 (AdipoR1). The present study was therefore planned to examine the effects of monomeric adiponectin on NO release and Ca(2+) transients in porcine aortic endothelial cells (PAEs) in normal/high glucose conditions and the related mechanisms. MAIN
METHODS: PAEs were treated with monomeric adiponectin alone or in the presence of intracellular kinases blocker, AdipoR1 and Ca(2+)-ATPase pump inhibitors. The role of Na(+)/Ca(2+) exchanger was examined in experiments performed in zero Na(+) medium. NO release and intracellular Ca(2+) were measured through specific probes. KEY
FINDINGS: In PAE cultured in normal glucose conditions, monomeric adiponectin elevated NO production and [Ca(2+)]c. Similar effects were observed in high glucose conditions, although the response was lower and not transient. The Ca(2+) mobilized by monomeric adiponectin originated from an intracellular pool thapsigargin- and ATP-sensitive and from the extracellular space. Moreover, the effects of monomeric adiponectin were prevented by kinase blockers and AdipoR1 inhibitor. Finally, in normal glucose condition, a role for Na(+)/Ca(2+) exchanger and Ca(2+)-ATPase pump in restoring Ca(2+) was found. SIGNIFICANCE: Our results add new information about the control of endothelial function elicited by monomeric adiponectin, which would be achieved by modulation of NO release and Ca(2+) transients. A signalling related to Akt, ERK1/2 and p38MAPK downstream AdipoR1 would be involved.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  AdipoR1; Adipokine; Calcium transients; Nitric oxide

Mesh:

Substances:

Year:  2016        PMID: 27469459     DOI: 10.1016/j.lfs.2016.07.010

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  6 in total

Review 1.  Vascular endothelial adiponectin signaling across the life span.

Authors:  Katie E Cohen; Boran Katunaric; Gopika SenthilKumar; Jennifer J McIntosh; Julie K Freed
Journal:  Am J Physiol Heart Circ Physiol       Date:  2021-11-19       Impact factor: 5.125

2.  Epoprostenol up-regulates serum adiponectin level in patients with systemic sclerosis: therapeutic implications.

Authors:  Anna Stochmal; Joanna Czuwara; Michał Zaremba; Lidia Rudnicka
Journal:  Arch Dermatol Res       Date:  2021-01-12       Impact factor: 3.017

3.  Monomeric adiponectin increases cell viability in porcine aortic endothelial cells cultured in normal and high glucose conditions: Data on kinases activation.

Authors:  Elena Grossini; Serena Farruggio; Fatima Qoqaiche; Giulia Raina; Lara Camillo; Lorenzo Sigaudo; David Mary; Nicola Surico; Daniela Surico
Journal:  Data Brief       Date:  2016-08-10

4.  Adiponectin Decreases Gastric Smooth Muscle Cell Excitability in Mice.

Authors:  Eglantina Idrizaj; Rachele Garella; Giovanni Castellini; Fabio Francini; Valdo Ricca; Maria Caterina Baccari; Roberta Squecco
Journal:  Front Physiol       Date:  2019-08-06       Impact factor: 4.566

5.  Exercise Improves Endothelial Function Associated with Alleviated Inflammation and Oxidative Stress of Perivascular Adipose Tissue in Type 2 Diabetic Mice.

Authors:  Jinju Wang; Venkata Polaki; Shuzhen Chen; Ji C Bihl
Journal:  Oxid Med Cell Longev       Date:  2020-12-26       Impact factor: 6.543

6.  Empagliflozin Regulates the AdipoR1/p-AMPK/p-ACC Pathway to Alleviate Lipid Deposition in Diabetic Nephropathy.

Authors:  Zhiqin Zhang; Lihua Ni; Lian Zhang; Dongqing Zha; Chun Hu; Lingli Zhang; Huiling Feng; Xiaobao Wei; Xiaoyan Wu
Journal:  Diabetes Metab Syndr Obes       Date:  2021-01-18       Impact factor: 3.168

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.